described the possibility of immunisation against IgA in IgA-deficient patients (i.e. selective IgA deficiency [sIgA], and common variable immunodeficiency [CVID]), leading to the development of anti-IgA Abs [3]. This evidence concerns the gene CD79A and common variable immunodeficiency.